U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403591) titled 'Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder' on Feb. 04.
Brief Summary: The purpose of this study is to investigate the effectiveness of a dual-target non-invasive brain stimulation technique called continuous Theta Burst Stimulation (cTBS) for treating Generalized Anxiety Disorder (GAD). The researchers will use a neuronavigation system, which acts like a GPS for the brain, to guide the stimulation to two specific targets: the left auditory association cortex and the primary motor cortex (M1).
Participants will be randomly assigned to one of two groups. One group will receive active dual-target...